KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
yahoo.com
gaming
2022-06-03 11:00:00

CAMBRIDGE, Mass. & SALISBURY, England, June 03, 2022--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted one newly-hired employee inducement options to purchase an aggregate of 20,000 shares of KalVista common stock on June 1, 2022 as inducement material to such employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

The options have an exercise price of $8.
